Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "Tuo Zhang"

  • Modify Search
  • Create Alert
  • Save Search

15 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 08/01/2017
e.g., 08/01/2017
Format Results
  • You have accessRestricted access
    Myocardin Induces Cardiomyocyte Hypertrophy
    Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson and Da-Zhi Wang
    Circulation Research. 2006;98:1089-1097, originally published April 27, 2006
    https://doi.org/10.1161/01.RES.0000218781.23144.3e
    Download PDF
  • You have access
    Myocardin Induces Cardiomyocyte Hypertrophy
    Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson, Da-Zhi Wang
    Circulation Research April 2006, 98 (8) 1089-1097; DOI: https://doi.org/10.1161/01.RES.0000218781.23144.3e
    By Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson and Da-Zhi Wang
    Figure 1. Upregulation of myocardin expression by hypertrophic signals. A, Neonatal rat cardiomyocytes grown in serum-free media were stimulated with...Show More
    Figure 1. Upregulation of myocardin expression by hypertrophic signals. A, Neonatal rat cardiomyocytes grown in serum-free media were stimulated with 10% serum or 100 μmol/L of PE for 48 hours or untreated to serve as control. Total RNAs were isolated and the expression of myocardin, ANF, and skeletal α-actin were examined by semiquantitative RT-PCR. GAPDH was used to serve as a loading control. B, The intensity of PCR products on the agarose gel image was quantified using the Photoshop Histogram Analysis and was plotted using Microsoft Excel and is shown as relative expression level after being normalized by GAPDH. C, Neonatal rat cardiomyocytes grown in serum-free media were stimulated with 10% FBS, 100 μmol/L of PE, or 104 units/mL of LIF for 24 hours and 48 hours, respectively. Untreated cardiomyocytes served as control. Total proteins were extracted, and the protein level for myocardin was detected by Western blot analysis. β-Tubulin was used as a loading control. D, The intensity of protein products from Western blot was quantified using the Photoshop Histogram Analysis and was plotted using Microsoft Excel and is shown as relative expression level after normalized by β-tubulin. E, Semiquantitative RT-PCR analysis of transcripts for myocardin, ANF, β-MHC, and skeletal α-actin (sk-α-actin) in TAB and control hearts. GAPDH was used to serve as a loading control. F, The intensity of PCR products on the agarose gel image was quantified using the Photoshop Histogram Analysis and was plotted using Microsoft Excel and is shown as relative expression level. G, Total proteins were extracted from wild-type (WT) and calcineurin (CnA) transgenic hearts, and the protein level for myocardin was detected by Western blot analysis. Protein extracts from wild-type mouse liver were used as a control. β-Tubulin was used as a loading control. H, Protein extracts from indicated human patient hearts with or without IDC were subjected to Western blot using antimyocardin antibody (top). Protein extracts from wild-type mouse liver were used as a control. β-Tubulin was used as a loading control. Error bars represent SD of two experiments. Statistical differences were determined using the Student t test; *P<0.05.Show Less
  • You have access
    Myocardin Induces Cardiomyocyte Hypertrophy
    Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson, Da-Zhi Wang
    Circulation Research April 2006, 98 (8) 1089-1097; DOI: https://doi.org/10.1161/01.RES.0000218781.23144.3e
    By Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson and Da-Zhi Wang
    Figure 2. Association of myocardin with the ANF promoter detected by ChIP assay. ChIP assays were performed using chromatin prepared from primary neon...Show More
    Figure 2. Association of myocardin with the ANF promoter detected by ChIP assay. ChIP assays were performed using chromatin prepared from primary neonatal cardiomyocytes in serum-free medium or after stimulation with PE (100 μmol/L) for 24 hours. Immunoprecipitations were performed without primary antibody (no Ab) or using a mouse IgG (IgG) as a control and with antimyocardin antibody as indicated. PCR primers for sequences associated with the promoters of the ANF and GAPDH genes were used.Show Less
  • You have access
    Myocardin Induces Cardiomyocyte Hypertrophy
    Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson, Da-Zhi Wang
    Circulation Research April 2006, 98 (8) 1089-1097; DOI: https://doi.org/10.1161/01.RES.0000218781.23144.3e
    By Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson and Da-Zhi Wang
    Figure 3. Myocardin activity is enhanced by hypertrophic stimuli in cardiomyocytes. Neonatal rat cardiomyocytes were transfected with the indicated lu...Show More
    Figure 3. Myocardin activity is enhanced by hypertrophic stimuli in cardiomyocytes. Neonatal rat cardiomyocytes were transfected with the indicated luciferase reporters and expression plasmids for myocardin. Twelve hours later, cells were treated with the indicated hypertrophic stimuli. Cells were harvested and luciferase activities were measured 36 hours after treatment. Values are expressed as the fold increase in luciferase activity in the presence of expression plasmid and hypertrophic stimuli above the level of activity with reporter plasmid alone. All experiments were repeated three times in duplicate. A, A pCDNA myocardin expression plasmid and ANF-luciferase reporter were transfected in the absence or presence of indicated hypertrophic agonists and luciferase activity was determined. B, A pCDNA myocardin expression plasmid and a luciferase reporter linked to the E1b basal promoter and four tandem copies of CArG box were transfected in the absence or presence of indicated hypertrophic agonists and luciferase activity was determined. C, An expression plasmid encoding full-length myocardin (1-935) fused to GAL4 (1-147) and the pL8G5-luciferase reporter were transfected in the absence or presence of indicated hypertrophic agonists, and luciferase activity was determined. D, An expression plasmid encoding myocardin TAD (713-935) fused to GAL4 (1-147) and the pL8G5-luciferase reporter were transfected in the absence or presence of indicated hypertrophic agonists, and luciferase activity was determined. Error bars represent SD of three independent experiments. Statistical differences were determined using the Student t test; *P<0.05.Show Less
  • You have access
    Myocardin Induces Cardiomyocyte Hypertrophy
    Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson, Da-Zhi Wang
    Circulation Research April 2006, 98 (8) 1089-1097; DOI: https://doi.org/10.1161/01.RES.0000218781.23144.3e
    By Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson and Da-Zhi Wang
    Figure 4. Overexpression of myocardin in cardiomyocytes. Primary neonatal cardiomyocytes were infected with Ad-lacZ, Ad-myocardin (Ad-MYCD), which was...Show More
    Figure 4. Overexpression of myocardin in cardiomyocytes. Primary neonatal cardiomyocytes were infected with Ad-lacZ, Ad-myocardin (Ad-MYCD), which was FLAG tagged, or a dominant-negative mutant of myocardin (Ad-MYCD-dn), also FLAG tagged, or treated with the indicated hypertrophic agonists. A, Myocardin protein was detected in cardiomyocytes using immunohistology (top) or Western blot analysis using anti-FLAG antibody (bottom). B, Cell surface area measurement in cardiomyocytes. The results are presented as mean±SE compared with the control, which is assigned a value of 1. n=40. Statistical differences were determined using the Student t test; *P<0.05.Show Less
  • You have access
    Myocardin Induces Cardiomyocyte Hypertrophy
    Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson, Da-Zhi Wang
    Circulation Research April 2006, 98 (8) 1089-1097; DOI: https://doi.org/10.1161/01.RES.0000218781.23144.3e
    By Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson and Da-Zhi Wang
    Figure 5. Induction of cardiomyocyte hypertrophy by myocardin. Primary neonatal cardiomyocytes were infected with Ad-lacZ, Ad-MYCD, Ad-MYCD-dn, or tre...Show More
    Figure 5. Induction of cardiomyocyte hypertrophy by myocardin. Primary neonatal cardiomyocytes were infected with Ad-lacZ, Ad-MYCD, Ad-MYCD-dn, or treated with indicated hypertrophic agonists. Two days later, cultures were fixed and stained with antibodies for α-actinin and ANF. Nontreated cardiomyocytes were used in control. Bar=50 μm.Show Less
  • You have access
    Myocardin Induces Cardiomyocyte Hypertrophy
    Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson, Da-Zhi Wang
    Circulation Research April 2006, 98 (8) 1089-1097; DOI: https://doi.org/10.1161/01.RES.0000218781.23144.3e
    By Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson and Da-Zhi Wang
    Figure 6. Inhibition of cardiomyocyte hypertrophy by a dominant-negative myocardin mutant. A, Primary neonatal cardiomyocytes were infected with Ad-la...Show More
    Figure 6. Inhibition of cardiomyocyte hypertrophy by a dominant-negative myocardin mutant. A, Primary neonatal cardiomyocytes were infected with Ad-lacZ or Ad-MYCD as indicated. Two days later, total RNA was isolated and semiquantitative RT-PCR analysis was performed. GAPDH was used to serve as a loading control. B, The intensity of PCR products on the agarose gel image was quantified using the Photoshop Histogram Analysis and was plotted using Microsoft Excel and is shown as relative expression level. C, Primary neonatal cardiomyocytes were infected with Ad-lacZ or Ad-MYCD-dn at an moi of 100 in the presence or absence of PE, as indicated (see Materials and Methods). Two days later, total RNA was isolated, and transcripts were detected by dot-blot hybridization. D, Results from dot-blot hybridization were quantified by PhosphoImager analysis, which is shown as relative expression level after being normalized against that of GAPDH. Error bars represent SD of two experiments. Statistical differences were determined using the Student t test; *P<0.05. SM-α-A indicates smooth muscle alpha-actin; SM-α-MHC, smooth muscle alpha-myosin heavy chain; α-CA, alpha cardiac activity; BNP, B-type natriuretic peptide.Show Less
  • You have access
    Myocardin Induces Cardiomyocyte Hypertrophy
    Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson, Da-Zhi Wang
    Circulation Research April 2006, 98 (8) 1089-1097; DOI: https://doi.org/10.1161/01.RES.0000218781.23144.3e
    By Weibing Xing, Tong-Cun Zhang, Dongsun Cao, Zhigao Wang, Christopher L. Antos, Shijie Li, Yibin Wang, Eric N. Olson and Da-Zhi Wang
    Figure 7. Inhibition of myocardin-induced cardiomyocyte hypertrophy by HDAC5. A, Primary neonatal cardiomyocytes were infected with Ad-MYCD or Ad-HDAC...Show More
    Figure 7. Inhibition of myocardin-induced cardiomyocyte hypertrophy by HDAC5. A, Primary neonatal cardiomyocytes were infected with Ad-MYCD or Ad-HDAC5 or both at an moi of 100, as indicated. Two days later, total RNA was isolated and transcripts were detected by dot-blot hybridization. B, Results from dot-blot hybridization were quantified by PhosphoImager analysis, which is shown as relative expression level after being normalized against that of GAPDH. Error bars represent SD of two experiments. C, Neonatal rat cardiomyocytes were transfected with ANF promoter luciferase reporters and expression plasmids for myocardin and HDAC5, as described in Materials and Methods. Forty-eight hours later, cells were harvested and luciferase activities were measured. Values are expressed as the fold increase in luciferase activity in the presence of expression plasmid and hypertrophic stimuli above the level of activity with reporter plasmid alone. All experiments were repeated four times in duplicate. Error bars represent SD of at least two experiments. Statistical differences were determined using the Student t test; *P<0.05.Show Less
  • You have access
    Independent Regulation of Cardiac Kv4.3 Potassium Channel Expression by Angiotensin II and Phenylephrine
    Ting-Ting Zhang, Koichi Takimoto, Alexandre F. R. Stewart, Chongxue Zhu, Edwin S. Levitan
    Circulation Research March 2001, 88 (5) 476-482; DOI: https://doi.org/10.1161/01.RES.88.5.476
    Figure 1.
    Figure 1.
    By Ting-Ting Zhang, Koichi Takimoto, Alexandre F. R. Stewart, Chongxue Zhu and Edwin S. Levitan
    Ang II and PE induce hypertrophic responses. Rat neonatal cardiac myocytes were treated with Ang II (100 nmol/L), PE (100 μmol/L), or vehicle for 8 or...Show More
    Ang II and PE induce hypertrophic responses. Rat neonatal cardiac myocytes were treated with Ang II (100 nmol/L), PE (100 μmol/L), or vehicle for 8 or 24 hours. Medium containing the agent or vehicle was changed every 12 hours. Amount of β-MHC mRNA was measured with RNase protection assay and normalized with an internal control β-actin mRNA (n≥3).Show Less
  • You have access
    Independent Regulation of Cardiac Kv4.3 Potassium Channel Expression by Angiotensin II and Phenylephrine
    Ting-Ting Zhang, Koichi Takimoto, Alexandre F. R. Stewart, Chongxue Zhu, Edwin S. Levitan
    Circulation Research March 2001, 88 (5) 476-482; DOI: https://doi.org/10.1161/01.RES.88.5.476
    Figure 2.
    Figure 2.
    By Ting-Ting Zhang, Koichi Takimoto, Alexandre F. R. Stewart, Chongxue Zhu and Edwin S. Levitan
    Ang II and PE decrease Kv4.3 mRNA and protein expression. A, Four days after plating, cells were treated with Ang II (100 nmol/L), PE (100 μmol/L), or...Show More
    Ang II and PE decrease Kv4.3 mRNA and protein expression. A, Four days after plating, cells were treated with Ang II (100 nmol/L), PE (100 μmol/L), or vehicle for 8 or 24 hours. Medium containing the agent or vehicle was changed every 12 hours. Myocytes were harvested, and Kv4.3 mRNAs were measured using RNase protection assay. In the upper 2 panels, β-actin mRNA was used as an internal control. Bottom panel shows results from an experiment with 8-hour treatments in which 28S ribosomal RNA was used as an internal control. P indicates probe; Y, yeast RNA; and C, control. B, Time courses of Ang II–induced and PE-induced Kv4.3 mRNA downregulation (n≥3 at each time point, normalization with β-actin). C, Three days after plating, cells were treated with Ang II (100 nmol/L), PE (100 μmol/L), or vehicle for 60 hours. Medium containing the agent or vehicle was changed every 24 hours. Total protein was isolated, and Kv4.3 proteins were detected using an anti-Kv4.3 antibody.Show Less

Pages

  • 1
  • 2
  • Next Page
Back to top

Selected Facets

Selected Facets

  • Hypertrophy (Article Type)

Publication Date

Publication date

  • 2003-2007 8
  • 1978-2002 7

Subject

Subject

  • ACE/Angiotension receptors 7
  • Gene expression 8
  • Gene regulation 15
  • Hypertrophy 15
  • Ion channels/membrane transport 7
  • Other myocardial biology 8
  • Physiological and pathological control of gene expression 15
  • Show More
  • Show Less

Content Type

Resource Type

  • Articles 1
  • Tables & Figures 14
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured